Diabetes, Endocrinology
Getting to the Heart of the Matter: Diabetes and Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction is the most common cause of hospitalization among patients with diabetes. Yet, despite its prevalence, this condition has been underrecognized and underdiagnosed. With the emergence of data on the impact of SGLT2 inhibitors and other medications beneficial to cardiovascular health, heart failure is becoming a key focus in the […]
DURATION
15 min
PROFESSION
Physician
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-12-12
Heart failure with preserved ejection fraction is the most common cause of hospitalization among patients with diabetes. Yet, despite its prevalence, this condition has been underrecognized and underdiagnosed. With the emergence of data on the impact of SGLT2 inhibitors and other medications beneficial to cardiovascular health, heart failure is becoming a key focus in the areas of diabetes management and cardiology.
In this expert brief, Dr. Sara Stafford and Dr. Jeff Winterstein discuss the presentation and diagnosis of health failure with preserved ejection fraction, the landmark trial data that is driving treatment of heart failure, and the exciting opportunities for diabetes and cardiorenal disease management.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk.
Faculty
Sara Stafford, MDCM FRCPC
Jeffrey Winterstein, MD, M.Sc., B.Sc., B.A.